Catalyst Event
Merck and Co Inc (MRK) · Other
From KEDI U.S. Quality500 + Monthly 1% Premium Index(NTR) (KUSQL500P)
6/12/2026, 12:00:00 AM
The U.S. FDA approved the combination of Welireg and Keytruda as an adjuvant treatment for ccRCC; High importance estimated due to significant market expansion for Keytruda.
Korean Translation
미국 FDA, 신세포암 보조 치료제로 벨주티판과 키트루다 병용 요법을 승인함; 키트루다의 시장 확대 가능성에 따라 높은 중요도로 예상됨.
Related Recent Events
ON Semiconductor Corp (ON) · Other
Financial Analyst Day scheduled in New York City to provide updates on company strategy, growth initiatives, and long-term financial plan. Low impact is anticipated as this is a routine strategy update scheduled
9/16/2026, 12:00:00 AM
Broadcom Inc (AVGO) · Earnings Release
Q3 2026 earnings release and conference call on September 3, 2026, for which the importance is estimated as High based on typical market reaction, scheduled.
9/3/2026, 12:00:00 AM
Marvell Technology Inc (MRVL) · Earnings Release
Marvell is expected to announce its Q2 fiscal 2027 earnings on or around August 27, 2026. This event is expected to have a price impact of at least 5% based on historical earnings volatility expected
8/27/2026, 12:00:00 AM
Walmart Inc (WMT) · Earnings Release
Walmart is scheduled to release its Q2 FY2027 earnings on August 20, 2026, before the market opens; a price impact of approximately 5% is estimated based on historical earnings volatility, scheduled.
8/20/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Other
A quarterly cash dividend of $0.53 per share was declared, with the ex-dividend date set for August 20, 2026.
8/20/2026, 12:00:00 AM
Keysight Technologies Inc (KEYS) · Earnings Release
Q3 2026 earnings release on August 18, 2026, with company revenue forecast of $1.730-$1.750 billion and non-GAAP EPS of $2.43-$2.49 (High importance estimated due to typical price volatility during earnings season) scheduled.
8/18/2026, 12:00:00 AM